All prices include GST and are in NZ dollars
-
Managing Chronic Obstructive Pulmonary Disease (COPD)
On Demand Respiratory System
Managing COPD is an interactive learning module designed to increase pharmacists’ knowledge, confidence and skills in the identification and management of patients with COPD. We have developed it in alignment with the NZ COPD Guidelines. At the completion of the course, you will be able to educate patients on evidence-based management of COPD and motivate them to engage in self-management practices.
-
MAVIRET Quality Use of Medicines - On Demand
Infections On Demand
MAVIRET® is a fully funded hepatitis C prescription medicine on the Pharmaceutical Schedule since February 2019.
If you wish to dispense MAVIRET®, pharmacists are required to complete the College MAVIRET® Quality Use of Medicines training course and your pharmacy needs to be enrolled in the AbbVie Care Pharmacy Programme.
-
Medicines Therapy Assessment (MTA) Portfolio
Accreditation Course On Demand
The Medicines Therapy Assessment (MTA) is a systematic, patient-centred clinical assessment of all medicines currently taken by a patient, identifying, resolving and preventing medication-related problems as well as optimising the effectiveness of medication treatment.
-
Medicines Use Review (MUR) Training Programme 2019 - On Demand
On Demand
The Medicines Use Review (MUR) Training Programme 2019 covers a number of topics which are relevant to conducting and documenting MUR consultations. Completing this Programme is required to become accredited and provide this service.
Learn about medication adherence, the medicine management services, the importance of privacy, culture and appropriate communication as well as how to maintain the quality of the service.
-
Molnupiravir (Lagevrio) - what a pharmacist needs to know
Immunological Products and Vaccines On Demand
This course provides information about Molnupiravir (Lagevrio®) the evidence, mechanism of action, a discussion of safety concerns and the management of interactions and use in different populations. The supply and patient eligibility criteria are also discussed.